These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 24931194)

  • 1. Constitutive activity in cannabinoid receptors.
    Fong TM
    Adv Pharmacol; 2014; 70():121-33. PubMed ID: 24931194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of inverse agonism of the cannabinoid receptors.
    Fong TM
    Methods Enzymol; 2010; 485():139-45. PubMed ID: 21050915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid CB1 receptors fail to cause relaxation, but couple via Gi/Go to the inhibition of adenylyl cyclase in carotid artery smooth muscle.
    Holland M; John Challiss RA; Standen NB; Boyle JP
    Br J Pharmacol; 1999 Oct; 128(3):597-604. PubMed ID: 10516638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SR144528 as inverse agonist of CB2 cannabinoid receptor.
    Rhee MH; Kim SK
    J Vet Sci; 2002 Sep; 3(3):179-84. PubMed ID: 12514329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverse agonism at serotonin and cannabinoid receptors.
    Aloyo VJ; Berg KA; Clarke WP; Spampinato U; Harvey JA
    Prog Mol Biol Transl Sci; 2010; 91():1-40. PubMed ID: 20691957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist.
    Portier M; Rinaldi-Carmona M; Pecceu F; Combes T; Poinot-Chazel C; Calandra B; Barth F; le Fur G; Casellas P
    J Pharmacol Exp Ther; 1999 Feb; 288(2):582-9. PubMed ID: 9918562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoid receptor pharmacology.
    Yao B; Mackie K
    Curr Top Behav Neurosci; 2009; 1():37-63. PubMed ID: 21104379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a cyclic adenosine monophosphate assay for Gi-coupled G protein-coupled receptors by utilizing the endogenous calcitonin activity in Chinese hamster ovary cells.
    Wang Y; Kong Y; Shei GJ; Kang L; Cvijic ME
    Assay Drug Dev Technol; 2011 Oct; 9(5):522-31. PubMed ID: 21561374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacology of cannabinoid receptors and their ligands: an overview.
    Pertwee RG
    Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S13-8. PubMed ID: 16570099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid receptors and their ligands.
    Pertwee RG; Ross RA
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):101-21. PubMed ID: 12052030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.
    Rinaldi-Carmona M; Barth F; Millan J; Derocq JM; Casellas P; Congy C; Oustric D; Sarran M; Bouaboula M; Calandra B; Portier M; Shire D; Brelière JC; Le Fur GL
    J Pharmacol Exp Ther; 1998 Feb; 284(2):644-50. PubMed ID: 9454810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
    Olianas MC; Maullu C; Onali P
    Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and characterization of highly constitutive active histamine H3 receptors.
    Takahashi K; Tokita S; Kotani H
    J Pharmacol Exp Ther; 2003 Oct; 307(1):213-8. PubMed ID: 12954820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of two cloned human CB1 cannabinoid receptor isoforms.
    Rinaldi-Carmona M; Calandra B; Shire D; Bouaboula M; Oustric D; Barth F; Casellas P; Ferrara P; Le Fur G
    J Pharmacol Exp Ther; 1996 Aug; 278(2):871-8. PubMed ID: 8768742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid receptors: where they are and what they do.
    Mackie K
    J Neuroendocrinol; 2008 May; 20 Suppl 1():10-4. PubMed ID: 18426493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive activity of histamine h(3) receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H(3) antagonists.
    Wieland K; Bongers G; Yamamoto Y; Hashimoto T; Yamatodani A; Menge WM; Timmerman H; Lovenberg TW; Leurs R
    J Pharmacol Exp Ther; 2001 Dec; 299(3):908-14. PubMed ID: 11714875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gi protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: implication for intracellular signalization cross-regulation.
    Bouaboula M; Desnoyer N; Carayon P; Combes T; Casellas P
    Mol Pharmacol; 1999 Mar; 55(3):473-80. PubMed ID: 10051530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse agonists and neutral antagonists of recombinant human A1 adenosine receptors stably expressed in Chinese hamster ovary cells.
    Shryock JC; Ozeck MJ; Belardinelli L
    Mol Pharmacol; 1998 May; 53(5):886-93. PubMed ID: 9584215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting constitutive activity and protean agonism at cannabinoid-2 receptor.
    Beltramo M; Brusa R; Mancini I; Scandroglio P
    Methods Enzymol; 2010; 484():31-51. PubMed ID: 21036225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of lipids and lipid signaling in the development of cannabinoid tolerance.
    Martin BR
    Life Sci; 2005 Aug; 77(14):1543-58. PubMed ID: 15949820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.